| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Accidental dextromethorphan poisoning |
Causative agent (attribute) |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional dextromethorphan poisoning |
Causative agent (attribute) |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| intoxication par le dextrométhorphane d'intention indéterminée |
Causative agent (attribute) |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| allergie au bromhydrate de dextrométhorphane |
Causative agent (attribute) |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/15mg/5mL/60mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/25mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/1mL/4mg/1mL/15mg/1mL liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Brompheniramine maleate+dextromethorphan hydrobromide+phenylpropanolamine hydrochloride 2mg/5mL 10mg/5mL 12.5mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 2mg/5mL 10mg/5mL 30mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride4mg/5mL 15mg/5mL60mg/5mL syrup (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Brompheniramine maleate + dextromethorphan hydrobromid + phenylpropanolamine hydrochl 2mg/10mg/12.5mg liquid (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextromethorphan hydrobromid + promethazine hydrochloride 15mg/6.25mg liquid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL 15mg/5mL 45mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride4mg/5mL 30mg/5mL60mg/5mL syrup (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 4mg/5mL/12.5mg/5mL/60mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride 1mg/1mL/4mg/1mL/15mg/1mL drop |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextromethorphan hydrobromide (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Poisoning caused by dextromethorphan (disorder) |
Causative agent (attribute) |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Brompheniramine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Carbinoxamine maleate+dextromethorphan hydrobromide+pseudoephedrine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextromethorphan hydrobromide 6.67mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextromethorphan 7.5mg pastille |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextromethorphan hydrobromide+promethazine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextromethorphan hydrobromide 7.5mg/5mL oral elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextromethorphan hydrobromide 7.5mg/5mL syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Brompheniramine maleate + dextromethorphan hydrobromide + phenylpropanolamine hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental dextromethorphan poisoning |
Causative agent (attribute) |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional dextromethorphan poisoning |
Causative agent (attribute) |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| allergie au bromhydrate de dextrométhorphane |
Causative agent (attribute) |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| allergie au bromhydrate de dextrométhorphane |
Causative agent (attribute) |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Dextromethorphan hydrobromide monohydrate (substance) |
Is a |
False |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Dextromethorphan hydrobromide monohydrate (substance) |
Is modification of (attribute) |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Dextromethorphan hydrobromide 3 mg/mL and promethazine hydrochloride 1.25 mg/mL oral solution |
Has precise active ingredient |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely brompheniramine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 9 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely dextromethorphan hydrobromide 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely dextromethorphan hydrobromide 1.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dextromethorphan hydrobromide 1.33 mg/mL oral solution |
Has precise active ingredient |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dextromethorphan hydrobromide 1.33 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dextromethorphan hydrobromide 30 mg and guaifenesin 600 mg prolonged-release oral tablet |
Has precise active ingredient |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL oral solution |
Has precise active ingredient |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Brompheniramine maleate 400 microgram/mL and dextromethorphan hydrobromide 2 mg/mL and pseudoephedrine hydrochloride 6 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet |
Has precise active ingredient |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely carbinoxamine maleate 1 milligram/1 milliliter and dextromethorphan hydrobromide 4 milligram/1 milliliter and pseudoephedrine hydrochloride 15 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 2.5 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
| Dextromethorphan hydrobromide anhydrous (substance) |
Is modification of (attribute) |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely dextromethorphan hydrobromide 7.5 milligram and paracetamol 500 milligram and promethazine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely dextromethorphan hydrobromide 7.5 milligram and paracetamol 500 milligram and promethazine hydrochloride 10 milligram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Dextromethorphan hydrobromide 750 microgram/mL and paracetamol 50 mg/mL and promethazine hydrochloride 1 mg/mL oral solution |
Has precise active ingredient |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Dextromethorphan hydrobromide 750 microgram/mL and paracetamol 50 mg/mL and promethazine hydrochloride 1 mg/mL oral solution |
Has basis of strength substance (attribute) |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely dextromethorphan hydrobromide 1.3 milligram/1 milliliter and diphenhydramine hydrochloride 2.8 milligram/1 milliliter and levomenthol 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing precisely dextromethorphan hydrobromide 1.3 milligram/1 milliliter and diphenhydramine hydrochloride 2.8 milligram/1 milliliter and levomenthol 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Dextromethorphan hydrobromide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]